Industry Roundup: P&G Leadership, Unilever Sale, Ad Claims
This article was originally published in The Tan Sheet
Executive Summary
Patterson Medical adds Performance Health; EarlySense targets consumer expansion; faster capsule filler available; and more news in brief.
You may also be interested in...
Cough/Cold, Analgesic Patch Sales Ease Pain Of Private Label Growth In OTCs
Topical analgesic sales grew double digits in 2017 on innovation and adhesive patch launches, helping drive 2.1% growth of US manufacturers' OTC drug sales in 2017 to $21.2bn, Kline & Co. independent consultant Laura Mahecha says. But private label continues to outpace branded product sales growth.
Cough/Cold, Analgesic Patch Sales Ease Pain Of Private Label Growth In OTCs
Topical analgesic sales grew double digits in 2017 on innovation and adhesive patch launches, helping drive 2.1% growth of US manufacturers' OTC drug sales in 2017 to $21.2bn, Kline & Co. independent consultant Laura Mahecha says. But private label continues to outpace branded product sales growth.
UK Short-Circuits OTC Device Pain Relief Claims For Diabetics, Arthritics
Ad claims for Actegy's Revitive Circulation Booster device did not rely on clinical evidence that tested the actual product in the way consumers were advised to use it, UK advertising regulator says. Actegy maintained benefits from the device's TENS technology are similar to the effects of NMES technology used in studies it offered as evidence.